Swiss National Bank »

Entrada Therapeutics shares owned by Swiss National Bank

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Swiss National Bank from 13F filings

Historical chart of Swiss National Bank investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Swiss National Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Swiss National Bank

Quarter filed Position value Share count Share price at filing
2023-12-31 $347k 23k 15.09
2023-09-30 $398k 25k 15.80
2023-06-30 $382k 25k 15.14
2023-03-31 $344k 24k 14.50
2022-12-31 $358k 27k 13.52